Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hope we see something soon! Really like how low the float is here!
Wonder if we can lock the float. I am in for 10K shares!
Will keep adding down here as funds allow. At some point if the float does not change and we get news this will go crazy!
Thanks good luck to you too!
This has to be one of the cheapest fully reporting stocks with this low of a float. Good risk reward at these levels IMO!
I am wondering if this was shorted. I mean how many shares do we own on this board. I picked up a good amount!
So per this post you stated the float was 142 million on 5/1/18.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140476884
Then on this post you stated the float had not been updated since 9/8/2016.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146483008
So you have selective information being posted here. Now you have claimed dilution in many posts. Yet your own post where you got that float # not having anything to do with the 9.8.2016 # shows there has been no dilution since 5/1/18.
At what point do you admit your dilution posts have not been accurate?
I would appreciate a reply to this post.
Oh and since you did not answer my question I will ask again what is your bid at?
So how much dilution has there been since you were bullish on the stock please share with the board...
What is your bid at?
Really?
This one looks interesting to me. Thinking of buying some shares just in case the float has not changed. If it has not on the next update well....
Nicely done!!!
Awaiting what you found out from the TA
Ok so given you want to help us please contact the TA which is not gagged and report your findings. Thanks in advance for your efforts!
CIIT RM 252K float MUST SEE VIDEO!!
CIIT RM 252K float MUST SEE VIDEO!!
CIIT moving!!
CIIT bid support now at 2!!
Looks like we may go over 2 today!
RM is what I am hopeful for. I have been adding and own a good amount of shares now! A good PR is all we need and I see the this going over .01 and very fast IMO!
CIIT RM 252K float MUST SEE VIDEO!!
CIIT RM MUST SEE VIDEO!!
CIIT RM MUST SEE VIDEO!!
Yes and just found this!!!
CHECK THIS OUT!! WOW!!
Yes the float is 142 million wonder why our expert could not find that info hmmm
Just amazing to me how a person acts like they are trying to help others out yet are flat out lying on this board!
Can you please educate me on how to get the float # in this stock. Since you want to help investors please I need help. Also, since you say there is dilution please help me determine how much there has been as of late. Please Please Please help! Also, any other investors need help here....
CIIT 252k float nice volume today!
252k float this can go huge holding all my shares for much bigger gains think this could go past 10.00 with the right volume!
So what is the unrestricted share count updated by the TA on 1/17/2019?
Really surprised with this low of a float that there is this much selling at the bid.
Amazing how there are daily claims of dilution yet it is so easy to see there is none.
So if what you are saying is true why is the float not changing on Otcmarkets.com which is TA verified.
Hope we get some good news on the acquisition soon. This stock is so thin!
CIIT just hit 1.00 very thin on level 2...
EBYH MJ stock 200K float trading at less than 1.00 with recent PR. This is the type of stock that could run to $5.00-$10.00 in a day with the right volume IMO!
Strainsforpains, Inc. Provides Corporate Update
Press Release | 01/17/2019
New York, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Strainsforpains, Inc. (OTC Pink:EBYH) is pleased to announce a shareholder update. As our focus since 2016 has been cannabis technology, we have developed an APP that will revolutionize the medical cannabis technology industry. With 33 states approving medical cannabis, we see substantial revenue growth for the industry over the next five years. We believe that our APP is essential in offering valuable, reliable and responsible information to consumers. We have attended and evaluated companies at numerous cannabis and 420 shows and will announce soon a portfolio of acquisitions and deals we are closing on.
As our DEMO is completing its BETA testing, we will launch our APP in the first quarter of 2019. We will subsequently start our advertising campaign, and we are in the process of selecting an advertising partner. Our APP is far advanced in anything out there today with a variety features, and easy end user accessibility. Management believes that 2019 will show strong revenue growth, and will continue to utilize this momentum in our acquisition strategies.
Our other focus is on CBD product distribution and sales. We feel that with Hemp legalization, CBD will greatly increase in usage and availability. With skyrocketing health care costs, most people are finally awakening to the values of CBD as a natural and safe alternative therapy, as well as cannabis for medical relief of pain. We will release announcements in the near future about our own CBD brand and consumer line of products. Management is also exploring the Canadian Cannabis market for acquisitions.
These two areas will greatly increase shareholder value, and we look forward to a very productive 2019. To learn more please visit our website at http://strainsforpains.com/ .
About Strainsforpains, Inc.
Strainsforpains, Inc. is an innovative healthcare technology company located in New York, N.Y. The Company's objectives are threefold: (1) To provide doctors, dispensaries and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of Cannabis combinations with major illnesses in a user friendly manner; and (2) acquisitions within the cannabis and CBD industry ; and (3) providing a line of CBD products in the marketplace.
Safe Harbor Statement
Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Strainsforpains, Inc's. ability to control, and those actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc.’s filings with the Securities and Exchange Commission.
Contact information: Yeshua Shainberg, info@strainsforpains.com, 646-481-4161
EBYH MJ stock 200K float trading at less than 1.00 with recent PR. This is the type of stock that could run to $5.00-$10.00 in a day with the right volume IMO!
Strainsforpains, Inc. Provides Corporate Update
Press Release | 01/17/2019
New York, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Strainsforpains, Inc. (OTC Pink:EBYH) is pleased to announce a shareholder update. As our focus since 2016 has been cannabis technology, we have developed an APP that will revolutionize the medical cannabis technology industry. With 33 states approving medical cannabis, we see substantial revenue growth for the industry over the next five years. We believe that our APP is essential in offering valuable, reliable and responsible information to consumers. We have attended and evaluated companies at numerous cannabis and 420 shows and will announce soon a portfolio of acquisitions and deals we are closing on.
As our DEMO is completing its BETA testing, we will launch our APP in the first quarter of 2019. We will subsequently start our advertising campaign, and we are in the process of selecting an advertising partner. Our APP is far advanced in anything out there today with a variety features, and easy end user accessibility. Management believes that 2019 will show strong revenue growth, and will continue to utilize this momentum in our acquisition strategies.
Our other focus is on CBD product distribution and sales. We feel that with Hemp legalization, CBD will greatly increase in usage and availability. With skyrocketing health care costs, most people are finally awakening to the values of CBD as a natural and safe alternative therapy, as well as cannabis for medical relief of pain. We will release announcements in the near future about our own CBD brand and consumer line of products. Management is also exploring the Canadian Cannabis market for acquisitions.
These two areas will greatly increase shareholder value, and we look forward to a very productive 2019. To learn more please visit our website at http://strainsforpains.com/ .
About Strainsforpains, Inc.
Strainsforpains, Inc. is an innovative healthcare technology company located in New York, N.Y. The Company's objectives are threefold: (1) To provide doctors, dispensaries and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of Cannabis combinations with major illnesses in a user friendly manner; and (2) acquisitions within the cannabis and CBD industry ; and (3) providing a line of CBD products in the marketplace.
Safe Harbor Statement
Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Strainsforpains, Inc's. ability to control, and those actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc.’s filings with the Securities and Exchange Commission.
Contact information: Yeshua Shainberg, info@strainsforpains.com, 646-481-4161
EBYH getting some volume not much left under 1.00